Index Venture Life Associates Vi LTD Centessa Pharmaceuticals PLC Transaction History
Index Venture Life Associates Vi LTD
- $167 Million
- Q4 2024
A detailed history of Index Venture Life Associates Vi LTD transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Index Venture Life Associates Vi LTD holds 9,961,789 shares of CNTA stock, worth $176 Million. This represents 99.89% of its overall portfolio holdings.
Number of Shares
9,961,789
Previous 9,961,789
-0.0%
Holding current value
$176 Million
Previous $40 Million
316.67%
% of portfolio
99.89%
Previous 100.0%
Shares
1 transactions
Others Institutions Holding CNTA
# of Institutions
116Shares Held
123MCall Options Held
5.9KPut Options Held
97.2K-
Medicxi Ventures Management (Jersey) LTD20MShares$352 Million73.44% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$171 Million5.81% of portfolio
-
Perceptive Advisors LLC New York, NY6.35MShares$112 Million3.55% of portfolio
-
First Light Asset Management, LLC Edina, MN5.81MShares$102 Million9.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.36MShares$94.5 Million0.01% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.66B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...